Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$974M |
| 2 |
Apple
AAPL
|
+$780M |
| 3 |
Amazon
AMZN
|
+$768M |
| 4 |
Kenvue
KVUE
|
+$659M |
| 5 |
Blackstone
BX
|
+$597M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$413M |
| 2 |
Texas Instruments
TXN
|
+$219M |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$202M |
| 4 |
Pfizer
PFE
|
+$192M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$145M |
Sector Composition
| 1 | Technology | 27.72% |
| 2 | Healthcare | 13.06% |
| 3 | Financials | 12.45% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Codexis
CDXS
$219M
| $2.63M | ﹤0.01% |
1,393,142
+50,839
| +4% | +$96.1K |
|
2977
InnovAge Holding
INNV
$616M
| $2.63M | ﹤0.01% |
439,361
+6,595
| +2% | +$39.5K |
|
2978
The Joint Corp
JYNT
$154M
| $2.62M | ﹤0.01% |
291,749
+11,238
| +4% | +$101K |
|
2979
Choiceone Financial
COFS
$455M
| $2.61M | ﹤0.01% |
132,935
+2,075
| +2% | +$40.8K |
|
2980
Kaltura
KLTR
$266M
| $2.61M | ﹤0.01% |
1,507,115
+3,632
| +0.2% | +$6.28K |
|
2981
CoreCard
CCRD
$211M
| $2.59M | ﹤0.01% |
129,693
+4,883
| +4% | +$97.7K |
|
2982
Red Robin
RRGB
$121M
| $2.58M | ﹤0.01% |
321,220
+8,673
| +3% | +$69.7K |
|
2983
MainStreet Bancshares
MNSB
$167M
| $2.57M | ﹤0.01% |
125,263
+2,482
| +2% | +$51K |
|
2984
The ONE Group
STKS
$81.1M
| $2.56M | ﹤0.01% |
465,460
+9,382
| +2% | +$51.6K |
|
|
SBDS
2985
Solo Brands, Inc.
SBDS
$26M
| $2.55M | ﹤0.01% |
499,185
+39,188
| +9% | +$200K |
|
2986
Talkspace
TALK
$429M
| $2.54M | ﹤0.01% |
1,303,715
+299,469
| +30% | +$584K |
|
|
KLRS
2987
Kalaris Therapeutics, Inc. Common Stock
KLRS
$72.8M
| $2.54M | ﹤0.01% |
51,271
+11,123
| +28% | +$550K |
|
2988
Cartesian Therapeutics
RNAC
$252M
| $2.53M | ﹤0.01% |
79,492
+583
| +0.7% | +$18.5K |
|
|
OKUR
2989
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$33.1M
| $2.52M | ﹤0.01% |
33,063
+3,617
| +12% | +$275K |
|
2990
dLocal
DLO
$4.03B
| $2.51M | ﹤0.01% |
130,954
-33,014
| -20% | -$633K |
|
2991
McEwen Inc.
MUX
$748M
| $2.5M | ﹤0.01% |
384,827
-809
| -0.2% | -$5.26K |
|
2992
MoonLake Immunotherapeutics
MLTX
$3.34B
| $2.5M | ﹤0.01% |
43,808
+11,840
| +37% | +$675K |
|
|
TRHC
2993
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $2.5M | ﹤0.01% |
242,088
+4,975
| +2% | +$51.3K |
|
2994
The RealReal
REAL
$1.09B
| $2.49M | ﹤0.01% |
1,182,104
+36,334
| +3% | +$76.7K |
|
2995
Inogen
INGN
$231M
| $2.49M | ﹤0.01% |
477,582
+8,129
| +2% | +$42.4K |
|
2996
Getty Images
GETY
$809M
| $2.49M | ﹤0.01% |
+383,108
| New | +$2.49M |
|
2997
Viemed Healthcare
VMD
$263M
| $2.47M | ﹤0.01% |
367,626
+24,919
| +7% | +$168K |
|
2998
Heron Therapeutics
HRTX
$193M
| $2.47M | ﹤0.01% |
2,395,161
+340,735
| +17% | +$351K |
|
2999
Alliance Resource Partners
ARLP
$2.92B
| $2.46M | ﹤0.01% |
109,342
+60
| +0.1% | +$1.35K |
|
3000
Crawford & Co Class A
CRD.A
$527M
| $2.46M | ﹤0.01% |
263,354
+7,132
| +3% | +$66.6K |
|